Inspire Medical Systems (NYSE:INSP) Trading Up 5.4% – Here’s Why

Posted by Brenda Bartman on Sep 9th, 2026

Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report)’s share price rose 5.4% on Wednesday . The stock traded as high as $64.25 and last traded at $65.5080. Approximately 148,769 shares were traded during mid-day trading, a decline of 86% from the average session volume of 1,075,850 shares. The stock had previously closed at $62.14.

Analysts Set New Price Targets

A number of brokerages recently issued reports on INSP. Weiss Ratings downgraded Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday. Piper Sandler lifted their price target on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Evercore set a $54.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. UBS Group began coverage on shares of Inspire Medical Systems in a report on Tuesday, July 28th. They issued a “sell” rating and a $39.00 price objective on the stock. Finally, Bank of America cut shares of Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 price objective for the company. in a research report on Friday, May 22nd. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $66.19.

View Our Latest Stock Report on Inspire Medical Systems

Inspire Medical Systems Stock Up 5.0%

The stock has a fifty day moving average of $55.76 and a 200-day moving average of $52.40. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of 14.16, a P/E/G ratio of 4.79 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.38. The company had revenue of $200.58 million for the quarter, compared to analyst estimates of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The business’s quarterly revenue was down 7.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post 1.24 EPS for the current fiscal year.

Insider Transactions at Inspire Medical Systems

In other news, insider Jason Kelly sold 963 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the transaction, the insider directly owned 18,985 shares of the company’s stock, valued at approximately $1,130,556.75. This represents a 4.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Inspire Medical Systems

A number of institutional investors and hedge funds have recently modified their holdings of the company. CWM LLC raised its stake in shares of Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after buying an additional 242 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in Inspire Medical Systems by 1,115.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock valued at $33,000 after acquiring an additional 580 shares during the last quarter. Havemeyer Place LP acquired a new stake in Inspire Medical Systems in the 4th quarter valued at about $39,000. Smartleaf Asset Management LLC increased its holdings in Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after acquiring an additional 205 shares in the last quarter. Finally, Versant Capital Management Inc raised its position in Inspire Medical Systems by 379.0% during the second quarter. Versant Capital Management Inc now owns 958 shares of the company’s stock worth $43,000 after acquiring an additional 758 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

About Inspire Medical Systems

(Get Free Report)

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.